Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

PFIZER AGREEMENT WITH NORTHWESTERN IN ANTI-TRUST SUIT STIPULATES

  • News

Executive Summary

PFIZER AGREEMENT WITH NORTHWESTERN IN ANTI-TRUST SUIT STIPULATES that the whslr. will not sell Pfizer products to its Pay 'N Save outlets. "Pfizer agreed to sell to Northwestern products at whsle. price where products are not re-sold to Pay 'N Save affiliated outlets," a Pfizer representative told "The Pink Sheet." The mfr. and Northwestern settled the suit on Oct. 12. Pfizer is the fourth company to reach a long-term settlement with Northwestern. Previously, Lilly, American Home Products, and Sandoz reached agreements with the whslr. ("The Pink Sheet" Oct. 1, p. 14). Lilly's agreement calls for the firm to supply Northwestern through June 1985. SmithKline remains as the sole mfr. defendant in the lawsuit. Last May, SmithKline arrived at an interim agreement with Northwestern's customer, the Velocity Hospital Buying Group, to provide normal chargeback allowances, pending the outcome of the suit. The case is scheduled to go to trial on Feb. 25, 1985.

Table

View full table

Tags:
Latest Headlines

Mismatch Between Growing Vaccine Pipeline and CDC’s ACIP Capacity

Keeping Track: Two Breakthrough Oncologics, Another Antibiotic Clear US FDA Along With Pfizer’s Hemophilia B Gene Therapy

Priority Review Vouchers: Tropical Disease Candidates Wait Years For FDA Action On Qualifying List

Pink Sheet Podcast: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics

See All
UsernamePublicRestriction

Register

PS007433

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By